Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality ...

Diagnostic imaging determined that in life, the young mamenchisaurid suffered from an osteogenic tumor, or a tumor that ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Researchers determined short-term blood pressure variability is an independent predictor of CTR-CVT in patients with multiple myeloma undergoing treatment with proteasome inhibitors.

Lymph node metastasis was uncommon among clinically node-negative PTC patients without evidence of nodal involvement on USG and CT.

DelveInsight's "Uterine Sarcoma Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Microsatellite Stable ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

A rice-sized microrobot offers precision in brain surgery, starting with tumor biopsies in a first clinical trial set for ...

In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

Europe’s minimal residual disease (MRD) testing market has witnessed remarkable growth, underscoring its pivotal role in healthcare diagnostics. Valued at $265.6 million in 2021, this market is poised ...